The role of Germline-Encoded T cell Receptor Complementarity Determining Regions in T cell Selection and Function
Author(s)
Holland, Stephen
Type
Thesis
Abstract
αβ T cell Receptors (TCR) recognise peptide antigen (p) presented on Major
Histocompatability Complexes (MHC) via Complementarity Determining Regions (CDRs).
TCRs are required to respond to a vast plethora of differing antigens and the CDR regions are
suitably diverse, encoded by an array of gene-segments, which recombine during T cell
development to generate diverse repertoires of TCRs. CDR1 and 2, which predominantly
interact with the MHC, are encoded within gene-segments, and are subject to evolutionary
pressure. However, CDR3 loops are non-germline and created through junctional diversity.
TCRs are ‘MHC restricted’ and only respond to antigen in the context of MHC. An influential
theory proposes that CDR1 and 2 have co-evolved with MHC and as such are inherently
predisposed towards MHC recognition. This thesis used preliminary data derived from whole
genome analysis of TCR CDR1 and 2 diversity relative to those of related immunoglobulins
(which are not MHC restricted) to determine if there is any relationship between germline
CDR diversity and MHC restriction. Conventional mutagenesis involving substituting CDR1
and 2 with artificial peptide linkers and replacement of βCDR1 and 2 with those of the related
yet MHC unrestricted γTCR chain was carried out in concert with a novel system that
embedded recombination cassettes into the CDR1 or 2 allowing in vivo generation and
selection of a library of non-germline CDR1 or 2 mutants. Collectively, these data strongly
infer a lack of requirement of germline CDR sequences in mediating MHC recognition in
both pMHC-mediated T cell development and function. However, alteration of the germline
sequence did affect the efficiency of T cell development, preference of MHC class type and
the diversity of the subsequent T cell repertoire. Thus, germline CDR structures may facilitate
a more diverse array of MHC docking modes to maximise the resultant TCR repertoire,
contributing to an increased capacity for cross-reactivity, rather than imposing MHC
restriction.
Histocompatability Complexes (MHC) via Complementarity Determining Regions (CDRs).
TCRs are required to respond to a vast plethora of differing antigens and the CDR regions are
suitably diverse, encoded by an array of gene-segments, which recombine during T cell
development to generate diverse repertoires of TCRs. CDR1 and 2, which predominantly
interact with the MHC, are encoded within gene-segments, and are subject to evolutionary
pressure. However, CDR3 loops are non-germline and created through junctional diversity.
TCRs are ‘MHC restricted’ and only respond to antigen in the context of MHC. An influential
theory proposes that CDR1 and 2 have co-evolved with MHC and as such are inherently
predisposed towards MHC recognition. This thesis used preliminary data derived from whole
genome analysis of TCR CDR1 and 2 diversity relative to those of related immunoglobulins
(which are not MHC restricted) to determine if there is any relationship between germline
CDR diversity and MHC restriction. Conventional mutagenesis involving substituting CDR1
and 2 with artificial peptide linkers and replacement of βCDR1 and 2 with those of the related
yet MHC unrestricted γTCR chain was carried out in concert with a novel system that
embedded recombination cassettes into the CDR1 or 2 allowing in vivo generation and
selection of a library of non-germline CDR1 or 2 mutants. Collectively, these data strongly
infer a lack of requirement of germline CDR sequences in mediating MHC recognition in
both pMHC-mediated T cell development and function. However, alteration of the germline
sequence did affect the efficiency of T cell development, preference of MHC class type and
the diversity of the subsequent T cell repertoire. Thus, germline CDR structures may facilitate
a more diverse array of MHC docking modes to maximise the resultant TCR repertoire,
contributing to an increased capacity for cross-reactivity, rather than imposing MHC
restriction.
Date Issued
2012-01
Date Awarded
2013-01
Copyright Statement
Attribution NoDerivatives 4.0 International Licence (CC BY-ND)
Advisor
Dyson, Julian
George, Andrew
Sponsor
Wellcome Trust (London, England)
Publisher Department
Medicine
Publisher Institution
Imperial College London
Qualification Level
Doctoral
Qualification Name
Doctor of Philosophy (PhD)